Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers
对布伦妥昔单抗和抗PD-1疗法耐药或不耐受的经典霍奇金淋巴瘤患者的治疗结果：来自15个美国学术中心的真实世界分析
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01257-1
Voorhees, Timothy J; McLaughlin, Eric M; Torka, Pallawi; Florindez, Jorge; Kim, Na Hyun; Moyo, Tamara K; Reves, Heather; Sumransub, Nuttavut; Deshpande, Saarang; Rose, Ashley; Duarte, Cassandra; Faisal, Muhammad Salman; Hamid, Showkat; Subbiah, Suki; Ayyappan, Sabarish; Shea, Lauren; Cortese, Matt; Patel, Krish; Major, Ajay; Saeed, Hayder; Svoboda, Jakub; Desai, Sanjal; Geethakumari, Praveen Ramakrishnan; Hamadani, Mehdi; Grover, Natalie; Epperla, Narendranath
